Protozoan metabolism

"Protozoan metabolism" is not the name of a specific molecule or receptor, but rather an umbrella term referring to the metabolic pathways present in protozoan organisms. Protozoa are single-celled eukaryotic microorganisms with diverse metabolic processes that allow them to survive in various environments and act as pathogens in humans and animals[3][7]. The term encompasses numerous enzymes, pathways, and transport systems such as glycolysis, the tricarboxylic acid cycle, and specialized organelles like mitochondria or hydrogenosomes[1][7]. Many anti-protozoal drugs and therapeutic strategies aim at disrupting one or more of these metabolic pathways[2][4][5][8], but "protozoan metabolism" itself is not a discrete, druggable entity and does not refer to a specific molecular target. Thus, it is not considered a therapeutic target in a structured sense, but rather describes the collective metabolic machinery that may harbor specific drug targets (such as enzymes: malate dehydrogenase, thioredoxin reductase, metacaspase, or ion transporters)[1][2][4][5].